How Can We Engineer CAR T Cells to Overcome Resistance?

被引:16
|
作者
Glover, Maya [1 ]
Avraamides, Stephanie [2 ]
Maher, John [1 ,2 ,3 ,4 ]
机构
[1] Guys Hosp, Leucid Bio Ltd, London SE1 9RT, England
[2] Guys Hosp, Kings Coll London, Sch Canc & Pharmaceut Sci, London SE1 9RT, England
[3] Kings Coll Hosp NHS Fdn Trust, Dept Clin Immunol & Allergy, London SE5 9RS, England
[4] Eastbourne Hosp, Dept Immunol, Eastbourne BN21 2UD, E Sussex, England
来源
基金
英国医学研究理事会; 英国惠康基金;
关键词
chimeric antigen receptor; cancer; immunotherapy; T-cell; resistance; CHIMERIC-ANTIGEN-RECEPTOR; FIBROBLAST ACTIVATION PROTEIN; ANTITUMOR-ACTIVITY; B-CELL; TUMOR-ANTIGEN; ADOPTIVE IMMUNOTHERAPY; SELECTIVE EXPANSION; INDUCE REMISSIONS; LYMPHOMA ACTIVITY; HOST IMMUNITY;
D O I
10.2147/BTT.S252568
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chimeric antigen receptor (CAR) T cell therapy has achieved unrivalled success in the treatment of B cell and plasma cell malignancies, with five CAR T cell products now approved by the US Food and Drug Administration (FDA). However, CAR T cell therapies for solid tumours have not been nearly as successful, owing to several additional challenges. Here, we discuss mechanisms of tumour resistance in CAR T cell therapy and the emerging strategies that are under development to engineer CAR T cells to overcome resistance.
引用
收藏
页码:175 / 198
页数:24
相关论文
共 50 条
  • [1] Radiation resistance: What is it? How can we overcome it?
    Dritschilo, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 123 - 123
  • [2] How can Cytokine-induced killer cells overcome CAR-T cell limits
    Cappuzzello, Elisa
    Vigolo, Emilia
    D'Accardio, Giulia
    Astori, Giuseppe
    Rosato, Antonio
    Sommaggio, Roberta
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Deficiency in AML Confers Resistance to CAR T-Cells That Can be Overcome By Targeting the Cholesterol or Wnt Pathways
    Mueller, Jan
    Schimmer, Roman
    Koch, Christian
    Schneiter, Florin
    Fullin, Jonas
    Lysenko, Veronika
    Myburgh, Renier
    Volta, Laura
    Theocharides, Alexandre
    Kurppa, Kari
    Ebert, Benjamin L.
    Schroeder, Timm
    Manz, Markus G.
    Boettcher, Steffen
    BLOOD, 2023, 142
  • [4] CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
    Kim, Gloria B.
    Hege, Kristen
    Riley, James L.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [5] Next-generation CAR T cells designed to overcome tumor resistance
    Mackall, Crystal L.
    CANCER RESEARCH, 2019, 79 (13)
  • [6] How Do We Overcome Resistance to Venetoclax
    Saxena, Kapil
    Carter, Bing Z.
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S55 - S57
  • [7] HOW CAN WE OVERCOME INTERRUPTIONS IN METAL SUPPLIES
    MESSNER, OHC
    METALL, 1980, 34 (05): : 472 - 475
  • [8] How can we overcome health inequalities in psychiatry?
    Monk-Cunliffe, Jonathan
    BJPSYCH BULLETIN, 2023, 47 (04): : 228 - 230
  • [9] Platinum drugs and taxanes: can we overcome resistance?
    Elena V. Sazonova
    Gelina S. Kopeina
    Evgeny N. Imyanitov
    Boris Zhivotovsky
    Cell Death Discovery, 7
  • [10] Platinum drugs and taxanes: can we overcome resistance?
    Sazonova, Elena V.
    Kopeina, Gelina S.
    Imyanitov, Evgeny N.
    Zhivotovsky, Boris
    CELL DEATH DISCOVERY, 2021, 7 (01)